Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome

American Journal of Surgical Pathology

Volumn 37, Issue 1, 2013, Pages 74-80

  Sanz Ortega, Julian ^a   Vocke, Cathy ^b   Stratton, Pamela ^c   Linehan, William Marston ^b   Merino, Maria J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

familial renal cancer syndrome; fumarate hydratase mutation; HLRCC; uterine leiomyoma

Indexed keywords

DNA; FUMARATE HYDRATASE; TUMOR MARKER;

ADULT; ARTICLE; CELL NUCLEUS; FAMILIAL CANCER; FEMALE; GENETICS; HETEROZYGOSITY LOSS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LEIOMYOMA; LEIOMYOMATOSIS; MIDDLE AGED; MUTATION; PATHOLOGY; SYNDROME; UTERUS CANCER;

ADULT; CARCINOMA, RENAL CELL; CELL NUCLEUS; DNA, NEOPLASM; FEMALE; FUMARATE HYDRATASE; GERM-LINE MUTATION; HUMANS; KIDNEY NEOPLASMS; LEIOMYOMA; LEIOMYOMATOSIS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; SYNDROME; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 84871619844     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31825ec16f     Document Type: Article

References (22)

1. Launonen V, Vierimaa O, Kiuru M, et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci. 2001;98:3387-3392.
2. Toro JR, Nickerson ML, Wei MH, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet. 2003;73:95-106.
3. Tomlinson IPM, Alam NA, Rowan AJ, et al. Germline mutations in FH predispose to dominantly inherited uterine leiomyomas, skin leio-myomata and papillary renal cell cancer. Nat Genet. 2002;30:406-410.
4. Wei M-H, Toure O, Glenn GM, et al. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet. 2006; 43:18-27.
5. Virchow R. About macroglossia and pathological formation of striated muscle fibers. Virchows Arch Pathol Anat. 1854;7:126-138.
6. Reed WB, Walker R, Horowitz R. Cutaneous leiomyomata with uterine leiomyomata. Acta Dermatol Venereol. 1973;53:409-416.
7. Fletcher CF. Pathology And Genetics of Tumours of the Soft Tissues And Bones (World Health Organization Classification of Tumours, ed. 2004.
8. Grubb RL 3rd, Franks ME, Toro J, et al. Hereditary leiomyoma-tosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol. 2007;177:2074-2079.
9. Ylisaukko-oja SK, Kiuru M, Lehtonen HJ, et al. Analysis of fumarate hydratase mutations in a population-based series of early onset uterine leiomyosarcoma patients. Int J Cancer. 2006;119: 283-287.
10. Alam NA, Leigh IM. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol. 2005;153:11-17.
11. Barker KT, Bevan S, Wang R, et al. Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. Br J Cancer. 2002;87:446-448.
12. Kiuru M, Lehtonen R, Arola J, et al. Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res. 2002;62:4554-4557.
13. Vanharanta S, Pollard PJ, Lehtonen HJ, et al. Distinct expression profile in fumarate-hydratase-deficient uterine leiomyomas. Hum Mol Genet. 2006;15:97-103.
14. Catherino WH, Mayers CM, Mantzouris T, et al. Compensatory alterations in energy homeostasis characterized in uterine tumors from hereditary leiomyomatosis and renal cell cancer. Fertil Steril. 2007;88:1039-1048.
15. Gross KL, Panhuysen CI, Kleinman MS, et al. Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: genetic linkage analysis and FISH studies. Genes Chromosomes Cancer. 2004;41:183-190.
16. Isaacs JS, Mole DR, Torres-Cabala C, et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell. 2005;8:143-153.
17. Kiuru M, Launonen V, Hietala M, et al. Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol. 2001;159:825-829.
18. Lehtonen R, Kiuru M, Vanharanta S, et al. Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyo-mas but is rare in other tumors. Am J Pathol. 2004;164:17-22.
19. Lehtonen H, MSkinen MJ, Kiuru M, et al. Increased HIF1 in SDH and FH deficient tumors does not cause microsatellite instability. Int J Cancer. 2007;121:1386-1389.
20. Linehan WM, Vasselli J, Srinivasan R, et al. Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res. 2004;10:6282S-6289S.
21. Martinez-Mir A, Glaser B, Chuang GS, et al. Germline fumarate hydratase mutations in families with multiple cutaneous and uterine leiomyomata. J Invest Dermatol. 2003;121:741-744.
22. Merino MJ, Torres-Cabala C, Pinto PA, et al. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 2007;31: 1578-1585.